Month: February 2024

Longeveron Reports Year-End 2023 Results and Provides Corporate Update

Written by Customer Service on February 27, 2024. Posted in Earnings Releases And Operating Results.

Company Announces 2024 Strategic Priorities Focused on Advancement of Lomecel-B™ in Hypoplastic Left Heart Syndrome ELPIS II Phase 2 Trial of Lomecel-B™ in HLHS Continues Enrollment; Completion of Study Enrollment Anticipated in 2024 Long-term Survival Data from ELPIS 1 Trial Presented at the 2023 Scientific Sessions of the American Heart Association Announced Additional Validating Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease Gross Proceeds of $6.4 Million in Equity Financing Secured in Q4 Registered Direct Offerings Company to Hold Conference Call and Webcast Today, February 27, 2023 at 5pm Eastern Time MIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”),...

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Guidance

Written by Customer Service on February 27, 2024. Posted in Earnings Releases And Operating Results.

PONTE VEDRA, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today reported financial results for the fourth quarter and full year ended December 31, 2023 and provided 2024 guidance. Recent HighlightsRevenue of $62.2 million in fourth quarter 2023 increased 25% over the same period in 2022; Revenue of $187.1 million for full-year 2023 increased 32% compared to prior year and was above the high end of previously provided revenue guidance range of $182 million to $186 million Blended average revenue per Lapiplasty® procedure kit sold in fourth quarter 2023 was $6,437, a record...

Myriad Genetics Reports Strong Fourth Quarter and Full-Year 2023 Financial Results; Fourth Quarter Revenue of $197 Million and Full-Year Revenue of $753 Million Each Grew 11% Year-Over-Year; Delivered GAAP EPS of $(0.36) and Adjusted EPS of $0.04 in the Fourth Quarter 2023; Raising 2024 Revenue Guidance

Written by Customer Service on February 27, 2024. Posted in Earnings Releases And Operating Results.

Highlights:Full-year testing volume grew 35% year-over-year, or 18% ex-SneakPeek® volume. Full-year 2023 revenue of $753 million, grew 11% year-over-year driven by Prenatal (30%, 15% ex-SneakPeek), Prolaris (21%), Pharmacogenomics (9%), and Hereditary Cancer (7%). Fourth quarter GAAP operating expenses of $166 million and adjusted operating expenses of $130 million, each down 6% year-over-year. Fourth quarter GAAP cash flow from operations was $(55) million; adjusted cash flow from operations was $14 million, an increase of $10 million year-over-year. Raised net proceeds of $118 million in equity offering in November 2023. In February 2024, Myriad Genetics acquired select assets from Intermountain Precision Genomics (“IPG”), including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory. Raising...

Jamf Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Written by Customer Service on February 27, 2024. Posted in Earnings Releases And Operating Results.

Q4 total revenue year-over-year growth of 16% to $150.6 million; fiscal year total revenue growth of 17% to $560.6 million ARR year-over-year growth of 15% to $588.6 million as of December 31, 2023 GAAP operating loss of $115.2 million, or (21)% of total revenue, compared to GAAP operating loss of $138.9 million, or (29)% of total revenue, in fiscal year 2022. Non-GAAP operating income of $45.4 million, or 8% of total revenue, compared to $25.9 million, or 5% of total revenue, for fiscal year 2022.MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) — Jamf (NASDAQ: JAMF), the standard in managing and securing Apple at work, today announced financial results for its fourth quarter and fiscal year ended December 31, 2023. “Jamf completed 2023 with solid results as organizations choose Jamf to enable an Apple-first, modern approach to...

Cenovus to webcast Investor Day 2024

Written by Customer Service on February 27, 2024. Posted in Public Companies.

CALGARY, Alberta, Feb. 27, 2024 (GLOBE NEWSWIRE) — Cenovus Energy Inc. (TSX:CVE) (NYSE: CVE) will hold its 2024 Investor Day in Toronto on Tuesday, March 5, 2024, at 8:30 a.m. ET (6:30 a.m. MT). Members of Cenovus’s Leadership Team will provide an update on the company’s strategy, outlook and operations to invited institutional investors and analysts. To accommodate a broader audience, the presentation will be webcast. The webcast and presentation will be available at cenovus.com by registering in advance at the Investors page’s Presentations and events section via the following link. Cenovus Energy Inc. Cenovus Energy Inc. is an integrated energy company with oil and natural gas production operations in Canada and the Asia Pacific region, and upgrading, refining and marketing operations in Canada and the United States. The company...

Aclarion Announces Closing of $3.0 Million Public Offering

Written by Customer Service on February 27, 2024. Posted in Public Companies.

BROOMFIELD, CO, Feb. 27, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Aclarion, Inc. (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced the closing of its public offering of 5,175,000 units, with each unit consisting of one share of common stock (or one pre-funded warrant in lieu thereof), and two common warrants, with each common warrant to purchase one share of common stock. Each unit was sold at a public offering price of $0.58. The common warrants are immediately exercisable at a price of $0.58 per share and expire five years from the date of issuance. The shares of common stock (or pre-funded warrants in lieu thereof) and accompanying...

Quest Resource Holding Corporation to Report Fourth Quarter and Fiscal Year 2023 Financial Results and Host Earnings Call on March 12, 2024

Written by Customer Service on February 27, 2024. Posted in Public Companies.

Metatron Apps and AB International Group Join Forces to Launch AI enhanced Movie Streaming Hub

Written by Customer Service on February 27, 2024. Posted in Public Companies.

DOVER, Del., Feb. 27, 2024 (GLOBE NEWSWIRE) — In an initiative aimed at revolutionizing the global digital entertainment landscape, Metatron Apps (OTC: MRNJ) and AB International Group (OTC: ABQQ) have accepted the initial terms of a collaboration via Letter of Intent. Metatron Apps brings to the table a rich history of developing hundreds of mobile apps, with several achieving top 20 rankings on the Apple App Store. AB International Group contributes its streaming rights for over 1000 Chinese movies and TV shows. The two entities have agreed via Letter of Intent (LOI) to develop a new, innovative video streaming platform. This project seeks to harness Metatron Apps’ app and AI technical expertise alongside AB International Group’s expansive content catalog, launching a top-tier movie streaming service with the goal...

QNB Corp. Declares Q1 2024 Dividend

Written by Customer Service on February 27, 2024. Posted in Dividend Reports And Estimates.

Quakertown, PA, Feb. 27, 2024 (GLOBE NEWSWIRE) — Quakertown, PA (27 February 2024) The Board of Directors of QNB Corp. (OTC Bulletin Board: QNBC), parent company of QNB Bank, at a regular meeting on February 27, declared a quarterly cash dividend of $0.37 per share. The cash dividend is payable on March 28, 2024, to shareholders of record March 15, 2024. QNB Corp. offers commercial and retail banking services through the twelve banking offices of its subsidiary, QNB Bank. QNB Corp.’s stock is traded in the over-the-counter market under the symbol “QNBC.” For more information, visit QNB’s website at QNBbank.com. CONTACT: David W. Freeman QNB Bank 2155385600 dfreeman@qnbbank.com

Toll Brothers Announces New Luxury Home Community Coming Soon to the Florida Panhandle

Written by Customer Service on February 27, 2024. Posted in Public Companies.

Breakwater by Toll BrothersBreakwater by Toll Brothers will feature a variety of single-family home designs just minutes from the turquoise waters and gorgeous beaches of the Gulf of Mexico.PANAMA CITY BEACH, Fla., Feb. 27, 2024 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community, Breakwater, is coming soon to the Panhandle of Florida. Located just minutes from the beaches of the Gulf of Mexico, Breakwater will be a lifestyle-driven gated community in the Ward Creek masterplan featuring luxury single-family homes with access to private onsite amenities. Construction of the Toll Brothers Sales Center and model homes will begin this spring, and sales will start in late summer of 2024. Breakwater is an exclusive, gated community featuring Toll...

Month: February 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals